LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer

Liu, Qi; Yang, Weihong; Luo, Ning; Liu, Jie; Wu, Yuliang; Ding, Jinye; Li, Caixia; Cheng, Zhongping

doi:10.7150/jca.41035

International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

open access Global reach, higher impact

Full Text | PDF

J Cancer 2020; 11(15):4413-4420. doi:10.7150/jca.41035 This issue Cite

Research Paper

LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer

Qi Liu¹, Weihong Yang¹, Ning Luo¹, Jie Liu¹, Yuliang Wu¹, Jinye Ding¹, Caixia Li¹, Zhongping Cheng^1,2✉

1. Department of Obstetrics and Gynecology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China
2. Institute of Gynecological Minimally Invasive Medicine, Tongji University School of Medicine, Shanghai, China

Citation:

Liu Q, Yang W, Luo N, Liu J, Wu Y, Ding J, Li C, Cheng Z. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. J Cancer 2020; 11(15):4413-4420. doi:10.7150/jca.41035. https://www.jcancer.org/v11p4413.htm

Other styles

Abstract

Background: Immunotherapy including immune checkpoint blockade, cancer vaccines, and adoptive cell therapy. However, no immune therapies support ovarian cancer. It is not clear whether the neutrophils, the component of the immune system derived from umbilical cord blood play a role in inhibiting the progression of ovarian cancer.

Methods: We investigate the impact of LPS and IL-8 activated neutrophils derived from umbilical cord blood(UCB)on ovarian cancer progression. After co-culture LPS and IL-8 activated UCB-derived neutrophils with ovarian cancer cell line SKOV3 and OVCAR3, CCK8, Transwell assay, and Flow Cytometry was performed to detect cell proliferation, migration, invasion, and apoptosis of ovarian cancer cell lines SKOV3 and OVCAR3. Furthermore, RT-PCR and western blotting assay were used to analyze the mechanism of metastasis and apoptosis of ovarian cancer cell lines respectively to support previous function experiments.

Results: We demonstrate LPS and IL-8 activated neutrophils derived from umbilical cord blood inhibit proliferation, invasion migration and promote apoptosis of SKOV3 and OVCAR3. Meanwhile, LPS and IL-8 activated UCB-derived neutrophils significantly decreased BAX and increased BCL2 expression in SKOV3 and OVCAR3 which account for the mechanism of apoptosis. Moreover, LPS and IL-8 activated UCB derived neutrophils significantly up-regulated E-cadherin and downregulated N-cadherin, MMP2 expression in SKOV3 and OVCAR3.

Conclusion: Taken together, these results approved that LPS and IL-8 activated neutrophils from UCB may be the novel strategy in immune therapy for ovarian cancer.

Keywords: Immunotherapy, Ovarian cancer, Neutrophils, Umbilical cord blood (UCB)

Citation styles

APA

Liu, Q., Yang, W., Luo, N., Liu, J., Wu, Y., Ding, J., Li, C., Cheng, Z. (2020). LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. Journal of Cancer, 11(15), 4413-4420. https://doi.org/10.7150/jca.41035.

ACS

Liu, Q.; Yang, W.; Luo, N.; Liu, J.; Wu, Y.; Ding, J.; Li, C.; Cheng, Z. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. J. Cancer 2020, 11 (15), 4413-4420. DOI: 10.7150/jca.41035.

NLM

CSE

Liu Q, Yang W, Luo N, Liu J, Wu Y, Ding J, Li C, Cheng Z. 2020. LPS and IL-8 activated umbilical cord blood-derived neutrophils inhibit the progression of ovarian cancer. J Cancer. 11(15):4413-4420.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.